Submitted:
04 July 2026
Posted:
06 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Settings
2.2. Sampling and Recruitment
2.3. Research Instruments
2.3.1. Quantitative Instrument
2.3.2. Qualitative Instrument
2.4. Data Collection
2.5. Measures
2.5. Data Analysis
2.5.1. Quantitative Analysis
2.5.2. Qualitative Analysis
2.5.3. Mixed-Methods Integration
2.6. Ethical Considerarions
3. Results
3.1. Quantitative Findings
3.1.1. Nursing students’socio-demographic characteristics, kowledge, attitudes, beliefs, and intentions to support medical cannabis legalization
3.1.2. Predictors of Intention To Support Medical Cannabis Use And Future Legalization Among Vietnamese Nursing Students
| Predictors | Univariable β |
OR1 (95% CI)2 | p-value |
Adjusted β | aOR3 (95%CI)2 | p-value |
|---|---|---|---|---|---|---|
| Age | 0.112 | 1.12 (1.02-1.22) | 0.014 | 0.028 | 1.03 (0.93–1.14) | 0.592 |
| Gender (Female vs Male) | 0.54 | 1.72 (1.10-2.65) | 0.017 | 0.351 | 1.42 (0.85–2.37) | 0.180 |
| Religion (Yes vs No) | 0.29 | 1.33 (0.88-2.10) | 0.17 | 0.324 | 1.38 (0.86–2.22) | 0.178 |
| Knowledge about MC | 0.069 | 1.07 (1.01-1.14) | 0.043 | 0.083 | 1.09 (1.01–1.18) | 0.043 |
| Attitude towards MC | 0.15 | 1.16 (1.12-1.21) | <0.001 | 0.006 | 1.01 (0.96–1.06) | 0.823 |
| Beliefs about MC | 0.402 | 1.5 (1.39-1.61) | <0.001 | 0.39 | 1.48 (1.35 –1.63) | <0.001 |
|
0.187 | 1.21 (1.03–1.41) | 0.021 | |||
|
0.792 | 2.21 (1.68–2.91) | <0.001 |
3.2. Qualitative Findings


3.3. Integration of Quantitative and Qualitative Findings
| Quantitative Findings | Qualitative Findings | Meta-inference |
|---|---|---|
|
Beliefs towards MC Moderately positive beliefs (68.1% of the maximum score). Beliefs regarding therapeutic benefits and safety/clinical integration were independently associated with greater support for MC legalization |
Theme 2: Concerns About Safety, Risks, and Ethical Use Participants recognized both the therapeutic benefits and potential risks of medical cannabis, including addiction, psychological adverse effects, ethical prescribing, and the need for standardized dosage and monitoring. |
Complementarity: OLR analysis identified beliefs as the strongest predictors of acceptance, whereas qualitative findings explained the specific beliefs influencing acceptance, including confidence in therapeutic effectiveness and concerns regarding safety and ethical use. |
|
Knowledge about MC Overall knowledge regarding medical cannabis (52.1% of the maximum score), with the highest performance in clinical practice considerations and the lowest in safety and adverse effects. |
Theme 1: Understanding and Perceived Therapeutic Value of Medical Cannabis NS demonstrated a basic understanding of medical cannabis, recognized its therapeutic indications, and viewed it as a potential alternative treatment. Limitations in knowledge about clinical use. |
Convergence: Both findings indicate that participants possessed basic but incomplete knowledge regarding medical cannabis, particularly concerning its safe clinical application. |
|
Attitudes towards MC Positive attitudes toward medical cannabis (73.5% of the maximum score), with strong scores for perceived health benefits, professional responsibility, and educational preparedness |
Theme 3: Professional Readiness for Clinical Implementation NS expressed positive professional attitudes toward the future clinical implementation of medical cannabis but emphasized the need for education, professional training, and evidence-based practice before its implementation |
Complementarity: Quantitative findings demonstrated positive attitudes, while qualitative findings explained that these attitudes were conditional upon adequate education, professional competence, and clinical guidelines. |
| Attitude was significant in the univariable analysis but was not independently associated with acceptance after adjustment for other predictors. | NS generally expressed favorable professional attitudes; however, they repeatedly highlighted inadequate preparedness and insufficient education regarding medical cannabis. | Divergence (partial): Although attitudes appeared positive descriptively, they did not independently predict acceptance after adjustment. Qualitative findings suggest that positive attitudes alone were insufficient to support acceptance without adequate knowledge, professional training, and confidence in safe clinical implementation. |
|
Intentions to support legalization of MC 32.7% of nursing students accepted future legalization of medical cannabis, and more than half remained undecided (56.2%). OLR analysis demonstrated that greater knowledge and stronger beliefs regarding therapeutic benefits and safety were associated with greater acceptance. |
Theme 4: Social, Legal, and Organizational Influences on Acceptance Participants expressed conditional support for legalization, emphasizing that legalization should occur only after scientific evidence, regulatory approval, public education, organizational preparedness, and protection of patient autonomy were established. |
Convergence: Both datasets indicate cautious rather than unconditional acceptance of medical cannabis. Acceptance depended on scientific evidence, safety, legal regulation, and healthcare system readiness. |
4. Discussion
4.1. Nursing Students Demonstrated Moderate Knowledge, Positive Attitudes and Beliefs Toward Medical Cannabis
4.2. Knowledge and Beliefs: Primary Predictors of Intention to Support Medical Cannabis Use and Future Legalization
4.3. Mixed-Methods Integration Providing a More Comprehensive Understanding of Nursing Students’ Intention to Support Medical Cannabis Use and Future Legalization
4.4. Implications for Nursing Education, Clinical Practice, and Healthcare Policy
4.5. Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Appendix A.1 Initial structured self-administered questionnaires
| PART 1: Socio-demographic characteristics of nursing students (Please check (✓) the box) | |
| A1 | Age..................years |
| A2 | Gender ☐ 1. Male ☐ 2. Female |
| A3 | Academic year 1st Year □ 2nd Year □ 3rd Year □ 4th Year □ |
| A4 | Religion 1. Yes □ 2. No □ |
| PART 2: Knowledge about medical cannabis related to efficacy, safety, and clinical application If you circle a correct answer, you get a score of 1 point. “I do not know” responses receive 0 points. The maximum score per question is 1 point. | ||||||
| K1 | What are the primary active compounds found in medical cannabis?” A) CBD (cannabidiol), and THC (tetrahydrocannabinol) B) Nicotine and Alcohol C) Caffeine and Aspirin D) Acetaminophen and Ibuprofen E) I do not know |
|||||
| K2 | Which of the following conditions has medical cannabis been shown to be effective in treating? A) Chronic Pain B) Common cold C) High Blood Pressure D) Diabetes E) Acute appendicitis |
|||||
| K3 | What are common side effects associated with medical cannabis use? A) Dizziness and Dry Mouth B) Blurred Vision and head ache C) Shortness of Breath and Chest Pain D) Increased Appetite and Weight Loss E) I do not know |
|||||
| K4 | Which statement is true regarding the safety of medical cannabis therapy? A) It has no known side effects or contraindications. B) It can be safely used with all other medications. C) It may interact with other medications and has contraindications. D) It is always the first line of treatment for chronic pain. E) I do not know |
|||||
| K5 | How is medical cannabis typically administered in a clinical setting? A) Orally, Inhalation, Topical, Sublingual B) Intravenous Injection only C) Transdermal Patch only D) Orally only E) I do not know |
|||||
| K6 | Which of the following medical conditions is NOT commonly treated with medical cannabis? A) Chronic Pain B) Glaucoma C) Asthma D) Epilepsy E) Multiple Sclerosis |
|||||
| K7 | In what form can medical cannabis NOT be administered? A) Oral (edibles) B) Inhalation (smoking/vaping) C) Transdermal (patches) D) Intravenous injection E) Topical (creams) |
|||||
| K8 | Which is a potential side effect of THC dominant cannabis use? A) Increased lung capacity B) Long-term memory enhancement C) Decreased appetite D) Psychoactive effects E) Decreased heart rate |
|||||
| K9 | Medical cannabis is considered potentially effective in the management of: A) Acute bacterial infections B) Chronic neuropathic pain C) Rapid weight gain D) Hyperactivity disorders E) Bone fractures |
|||||
| K10 | In clinical practice, nursing considerations when administering medical cannabis should include: A) Ignoring patient’s past experience with cannabis. B) Avoiding discussion about potential side effects. C) Administering the highest dose first. D) Monitoring for drug-drug interactions. E) Assuming all forms of cannabis are equal in effectiveness. |
|||||
| K11 | What is a critical consideration for nurses when administering cannabis oil to patients? A) Ensuring it is taken on an empty stomach B) Mixing it with caffeinated beverages for faster absorption C) Monitoring for potential side effects such as drowsiness D) Advising patients to drive immediately after administration to assess alertness E) Recommending it as the first-line treatment for pain |
|||||
| K12 | When educating patients about the use of medical cannabis, What is important to mention? A) It can be prescribed for any type of pain without evaluation B) It does not interact with any other medications C) Safe storage and proper dosing are crucial to prevent misuse D) It is always completely free of side effects E) It is effective as a sole treatment for cancer |
|||||
| K13 | Among the following, which is NOT a recognized potential side effect of medical cannabis? A) Dry mouth B) Increased appetite C) Blurred vision [Correct] D) Dizziness E) Altered mood |
|||||
| K14 | In clinical settings, the decision to use medical cannabis should always consider: A) The patient’s preference alone B) Celebrity endorsements C) The cost of the medication only D) A comprehensive assessment of the patient’s condition and history E) Availability of flavors or types of cannabis |
|||||
| K15 | Medical cannabis used in palliative care aims to: A) Completely cure the underlying condition B) Act as a substitute for all other medications C) Primarily enhance patient mobility D) Provide symptomatic relief and improve quality of life E) Be used as the initial step in diagnosing patients |
|||||
| K16 | Cannabis has been hypothesized to play a role in: A) Cognitive enhancement B) Weight loss C) Sleep regulation D) Blood pressure control E) I don’t know |
|||||
| K17 | For irritable bowel syndrome (IBS), cannabis has been A) Proven effective in numerous trials B) Shown to have a significant impact on symptoms C) Found to have no effect on gastric, small bowel or colonic transit D) Identified as the first-line treatment E) I don’t know |
|||||
| K18 | What type of pain was most commonly studied in trials investigating the effectiveness of cannabis for chronic pain? A. Arthritic pain B. Neuropathic pain C. Post-surgical pain D. Cancer pain E. All is correct |
|||||
| PART 3: Attitudes about medical cannabis. For a survey aimed at gauging attitudes and beliefs towards medical cannabis (MC) in Vietnam, where its legalization might be anticipated in the future, the following items can be developed using a 5-point Likert Scale. Read each sentence and tick (✓) in the appropriate box. There is no right or wrong answer. And don’t dwell too long on any one sentence. Degree evaluation: 1. “Strongly disagree” 2. “Disagree” 3. “Neutral” 4. “Agree” 5. “Strongly agree” | ||||||
| (1) | (2) | (3) | (4) | (5) | ||
| A1 | Medical cannabis has a significant therapeutic potential that is currently underestimated in countries not permitting medical cannabis use | ☐ | ☐ | ☐ | ☐ | ☐ |
| A2 | The benefits of using medical cannabis in treating certain medical conditions outweigh the potential risks. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A3 | I am concerned that the legalization of medical cannabis in Vietnam could lead to increased recreational use among the youth | ☐ | ☐ | ☐ | ☐ | ☐ |
| A4 | The lack of comprehensive research on medical cannabis makes it an unsafe treatment option | ☐ | ☐ | ☐ | ☐ | ☐ |
| A5 | If legalized, physicians in Vietnam should recommend cannabis as a medical therapy. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A6 | Training about medical cannabis should be incorporated into academic curricula of medicine and nursing in Vietnam | ☐ | ☐ | ☐ | ☐ | ☐ |
| A7 | Healthcare professionals should have formal training about medical cannabis before recommending it to patients, if it were legalized in Vietnam. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A8 | The potential side effects of medical cannabis are concerning to me. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A9 | It is ethically acceptable for healthcare professionals to administer medical cannabis if it benefits the patient | ☐ | ☐ | ☐ | ☐ | ☐ |
| A10 | I would feel ethically comfortable recommending medical cannabis to patients if it were legal and supported by scientific evidence. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A11 | I am concerned about the potential for dependency or misuse of medical cannabis by patients. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A12 | Legalizing medical cannabis would have a positive impact on the healthcare system. | ☐ | ☐ | ☐ | ☐ | ☐ |

| PART 5: Intention to support the legalization of medical cannabis (Please check (✓) the box) |
| Do you accept the use and support for legalization of medical cannabis in healthcare settings in the future? ☐ 1. Not accept ☐ 2. Undecided ☐ 3. Accept |
Appendix A.2 Final structured self-administered questionnaire used in the survey
| Time | Day …… Month ..…. Year 2024 Collector’s name :…………….. |
Participant ID: …………………………………… |
| PART 1: Socio-demographic characteristics of nursing students (Please check (✓) the box) | ||||||
| A1 | Age..................years | |||||
| A2 | Gender ☐ 1. Male ☐ 2. Female |
|||||
| A3 | Academic year 1st Year □ 2nd Year □ 3rd Year □ 4th Year □ |
|||||
| A4 | Religion 1. Yes □ 2. No □ |
|||||
| PART 2: Knowledge about medical cannabis related to efficacy, safety, and clinical application If you circle a correct answer, you get a score of 1 point. “I do not know” responses receive 0 points. The maximum score per question is 1 point. | ||||||
| K1 | What are the primary active compounds found in medical cannabis?” A) CBD (cannabidiol), and THC (tetrahydrocannabinol) B) Nicotine and Alcohol C) Caffeine and Aspirin D) Acetaminophen and Ibuprofen E) I do not know |
|||||
| K2 | Which of the following conditions has medical cannabis been shown to be effective in treating? A) Chronic Pain B) Common cold C) High Blood Pressure D) Diabetes E) Acute appendicitis |
|||||
| K3 | What are common side effects associated with medical cannabis use? A) Dizziness and Dry Mouth B) Blurred Vision and head ache C) Shortness of Breath and Chest Pain D) Increased Appetite and Weight Loss E) I do not know |
|||||
| K4 | Which statement is true regarding the safety of medical cannabis therapy? A) It has no known side effects or contraindications. B) It can be safely used with all other medications. C) It may interact with other medications and has contraindications. D) It is always the first line of treatment for chronic pain. E) I do not know |
|||||
| K5 | How is medical cannabis typically administered in a clinical setting? A) Orally, Inhalation, Topical, Sublingual B) Intravenous Injection only C) Transdermal Patch only D) Orally only E) I do not know |
|||||
| K6 | Which of the following medical conditions is NOT commonly treated with medical cannabis? A) Chronic Pain B) Glaucoma C) Asthma D) Epilepsy E) Multiple Sclerosis |
|||||
| K7 | In what form can medical cannabis NOT be administered? A) Oral (edibles) B) Inhalation (smoking/vaping) C) Transdermal (patches) D) Intravenous injection E) Topical (creams) |
|||||
| K8 | Which is a potential side effect of THC dominant cannabis use? A) Increased lung capacity B) Long-term memory enhancement C) Decreased appetite D) Psychoactive effects E) Decreased heart rate |
|||||
| K9 | Medical cannabis is considered potentially effective in the management of: A) Acute bacterial infections B) Chronic neuropathic pain C) Rapid weight gain D) Hyperactivity disorders E) Bone fractures |
|||||
| K10 | In clinical practice, nursing considerations when administering medical cannabis should include: A) Ignoring patient’s past experience with cannabis. B) Avoiding discussion about potential side effects. C) Administering the highest dose first. D) Monitoring for drug-drug interactions. E) Assuming all forms of cannabis are equal in effectiveness. |
|||||
| K11 | What is a critical consideration for nurses when administering cannabis oil to patients? A) Ensuring it is taken on an empty stomach B) Mixing it with caffeinated beverages for faster absorption C) Monitoring for potential side effects such as drowsiness D) Advising patients to drive immediately after administration to assess alertness E) Recommending it as the first-line treatment for pain |
|||||
| K12 | Among the following, which is NOT a recognized potential side effect of medical cannabis? A) Dry mouth B) Increased appetite C) Blurred vision [Correct] D) Dizziness E) Altered mood |
|||||
| K13 | In clinical settings, the decision to use medical cannabis should always consider: A) The patient’s preference alone B) Celebrity endorsements C) The cost of the medication only D) A comprehensive assessment of the patient’s condition and history E) Availability of flavors or types of cannabis |
|||||
| K14 | Medical cannabis used in palliative care aims to: A) Completely cure the underlying condition B) Act as a substitute for all other medications C) Primarily enhance patient mobility D) Provide symptomatic relief and improve quality of life E) Be used as the initial step in diagnosing patients |
|||||
| K15 | Cannabis has been hypothesized to play a role in: A) Cognitive enhancement B) Weight loss C) Sleep regulation D) Blood pressure control E) I don’t know |
|||||
| K16 | What type of pain was most commonly studied in trials investigating the effectiveness of cannabis for chronic pain? A. Arthritic pain B. Neuropathic pain C. Post-surgical pain D. Cancer pain E. All is correct |
|||||
| PART 3: Attitudes about medical cannabis. For a survey aimed at gauging attitudes and beliefs towards medical cannabis (MC) in Vietnam, where its legalization might be anticipated in the future, the following items can be developed using a 5-point Likert Scale. Read each sentence and tick (✓) in the appropriate box. There is no right or wrong answer. And don’t dwell too long on any one sentence. Degree evaluation: 1. “Strongly disagree” 2. “Disagree” 3. “Neutral” 4. “Agree” 5. “Strongly agree” | ||||||
| (1) | (2) | (3) | (4) | (5) | ||
| A1 | Medical cannabis has a significant therapeutic potential that is currently underestimated in countries not permitting medical cannabis use | ☐ | ☐ | ☐ | ☐ | ☐ |
| A2 | The benefits of using medical cannabis in treating certain medical conditions outweigh the potential risks. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A3 | I am concerned that the legalization of medical cannabis in Vietnam could lead to increased recreational use among the youth | ☐ | ☐ | ☐ | ☐ | ☐ |
| A4 | The lack of comprehensive research on medical cannabis makes it an unsafe treatment option | ☐ | ☐ | ☐ | ☐ | ☐ |
| A5 | If legalized, physicians in Vietnam should recommend cannabis as a medical therapy. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A6 | Training about medical cannabis should be incorporated into academic curricula of medicine and nursing in Vietnam | ☐ | ☐ | ☐ | ☐ | ☐ |
| A7 | Healthcare professionals should have formal training about medical cannabis before recommending it to patients, if it were legalized in Vietnam. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A8 | The potential side effects of medical cannabis are concerning to me. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A9 | It is ethically acceptable for healthcare professionals to administer medical cannabis if it benefits the patient | ☐ | ☐ | ☐ | ☐ | ☐ |
| A10 | I would feel ethically comfortable recommending medical cannabis to patients if it were legal and supported by scientific evidence. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A11 | I am concerned about the potential for dependency or misuse of medical cannabis by patients. | ☐ | ☐ | ☐ | ☐ | ☐ |
| A12 | Legalizing medical cannabis would have a positive impact on the healthcare system. | ☐ | ☐ | ☐ | ☐ | ☐ |


| PART 5: Intention to support the legalization of medical cannabis (Please check (✓) the box) |
| Do you accept the use and support for legalization of medical cannabis in healthcare settings in the future? ☐ 1. Not accept ☐ 2. Undecided ☐ 3. Accept |
Appendix B
| Authors (Year) | Population/ Setting | Knowledge | Attitude | Belief | Contribution to current instrument |
|---|---|---|---|---|---|
| Balneaves et al. (2023) [13] | Nursing students in Canada | THC/CBD, therapeutic uses, regulations, administration routes, safety precautions, cannabis regulations | Professional preparedness, stigma concerns | Therapeutic benefits for symptom management | Guided development of items related to MC pharmacology, administration methods, safety considerations, and professional competency in nursing practice |
| Sokratous et al. (2022) [11] | Nurses and midwives in Cyprus | Risks and benefits of MC; effectiveness for muscle spasms, insomnia, mental health conditions, and terminal illnesses | Need for formal training before recommending MC | Therapeutic benefits and potential mental/physical health risks; professional preparedness | Items related to therapeutic effectiveness, safety concerns, educational preparedness, and professional training needs |
| Balneaves et al. (2018) [16] | Canadian nurse practitioners | Therapeutic uses, risks and precautions, dosing, administration routes, cannabis products, and legal regulations regarding therapeutic cannabis | Professional comfort and acceptance of authorizing medical cannabis; importance of additional education and training | Uncertainty regarding therapeutic value, benefits, risks, and prescribing liability concerns | items related to MC therapeutic applications, safety considerations, administration methods, legal awareness, professional preparedness, and educational needs among nursing students |
| Zolotov et al. (2021) [10] | Israeli and American nursing students | Effectiveness of MC for chronic pain, cancer-related symptoms, terminal illnesses, arthritis, fibromyalgia, insomnia, epilepsy, multiple sclerosis, and nausea | Attitudes toward therapeutic benefits, addiction concerns, mental and physical health risks, and the importance of further MC research | Not explicitly assessed | Items related to therapeutic effectiveness, perceived addiction and health risks, professional responsibility, and the need for evidence-based clinical monitoring in MC practice |
| Khamenka & Pikirenia (2021) [12] |
Medical students in Belarus | Effectiveness of MC for chronic pain, mental health conditions, insomnia, cancer-related conditions, terminal illnesses, and persistent muscle spasms | Acceptance of MC treatment and recommendation; concerns regarding addiction and physical/mental health risks; professional responsibility and need for further research | Beliefs regarding therapeutic benefits and preparedness to address patient questions despite restrictive cannabis policies | Items related to therapeutic effectiveness, perceived addiction and health risks, professional responsibility, research needs, and preparedness for future MC implementation in restrictive policy settings |
| Felnhofer et al. (2021) [18] | Austrian university students | Differences between CBD and THC; therapeutic indications of MC for chronic pain, oncological diseases, palliative care, and psychiatric conditions | Attitudes toward physician prescribing, mandatory treatment recommendations, recreational legalization, addiction concerns, and inclusion of MC in medical curricula | Not explicitly assessed | items related to MC pharmacological knowledge, therapeutic indications, legalization attitudes, addiction concerns, and educational needs regarding MC training in healthcare curricula |
| Pereira et al. (2020) [17] | Nursing students in Spain | Knowledge regarding therapeutic indications and adverse effects of MC, including cancer, multiple sclerosis, muscle spasms, paranoia, dizziness, hallucinations, nausea, depression, and somnolence | Attitudes toward legalization of medical marijuana and concerns regarding misuse and potential detrimental health effects | Not explicitly assessed | items related to therapeutic indications, adverse effects, legalization attitudes, and perceived risks associated with MC use |
| Constructs | Subdomains | Item codes |
|---|---|---|
| Knowledge | Basic knowledge (active compound and administrative use) | K1,K5,and K7 |
| Therapeutic uses and effectiveness | K2,K6,K9, K15 , K16, and K18 | |
| Safety considerations and adverse effects | K3, K4, K8, and K13 | |
| Clinical MC practice | K10, K11, and K14 | |
| Attitudes | Perceived health risks and misuse | A3, A4, A8, and A11 |
| Perceived benefit and effectiveness | A1 and A2 | |
| MC legalization perspectives | A5 and A12 | |
| Educational needs and preparedness | A6 and A7 | |
| Professional responsibility | A9 and A10 | |
| Beliefs | Therapeutic benefits | B1, B2, B4, and B8 |
| Safety and clinical integration | B3 and B7 |
| Items/ questionnaire | Expert 1 | Expert 2 | Expert 3 | I-CVI |
|---|---|---|---|---|
| PART 1: Socio-demographic characteristics of nursing student | ||||
| A1 | 4 | 4 | 4 | 1 |
| A2 | 4 | 4 | 4 | 1 |
| A3 | 4 | 4 | 4 | 1 |
| A4 | 4 | 4 | 4 | 1 |
| PART 2: Knowledge about medical cannabis related to efficacy, safety, and clinical application | ||||
| K1 | 4 | 4 | 4 | 1 |
| K2 | 4 | 4 | 4 | 1 |
| K3 | 4 | 4 | 4 | 1 |
| K4 | 4 | 4 | 4 | 1 |
| K5 | 4 | 4 | 4 | 1 |
| K6 | 4 | 4 | 4 | 1 |
| K7 | 4 | 4 | 4 | 1 |
| K8 | 4 | 4 | 4 | 1 |
| K9 | 4 | 4 | 4 | 1 |
| K10 | 4 | 4 | 4 | 1 |
| K11 | 4 | 4 | 4 | 1 |
| K12 | 4 | 4 | 4 | 1 |
| K13 | 4 | 4 | 4 | 1 |
| K14 | 4 | 4 | 4 | 1 |
| K15 | 4 | 4 | 4 | 1 |
| K16 | 4 | 4 | 4 | 1 |
| K17 | 4 | 4 | 4 | 1 |
| K18 | 4 | 4 | 4 | 1 |
| PART 3: Attitudes about medical cannabis. | ||||
| A1 | 3 | 4 | 4 | 1 |
| A2 | 3 | 4 | 4 | 1 |
| A3 | 2 | 4 | 4 | 0.67 |
| A4 | 4 | 4 | 4 | 1 |
| A5 | 4 | 3 | 4 | 1 |
| A6 | 4 | 4 | 4 | 1 |
| A7 | 4 | 3 | 4 | 1 |
| A8 | 4 | 4 | 4 | 1 |
| A9 | 3 | 4 | 4 | 1 |
| A10 | 2 | 4 | 4 | 0.67 |
| A11 | 4 | 4 | 4 | 1 |
| A12 | 4 | 4 | 2 | 0.67 |
| PART 4: Beliefs about MC Benefits and risks | ||||
| B1 | 4 | 4 | 3 | 1 |
| B2 | 3 | 4 | 4 | 1 |
| B3 | 2 | 4 | 4 | 0.67 |
| B4 | 2 | 4 | 4 | 0.67 |
| B5 | 3 | 4 | 4 | 1 |
| B6 | 3 | 4 | 4 | 1 |
| B7 | 4 | 4 | 3 | 1 |
| B8 | 2 | 4 | 4 | 0.67 |
| PART 5: Intention to support the legalization of medical cannabis | 4 | 4 | 4 | 1 |
| S-CVI/Ave = 0.95 S-CVI/UA=0.86 | ||||
| Domain | Initial items | Final items | Cronbach’s Alpha (Initial) | Cronbach’s Alpha (Final) | Interpretation | Removed Items | Reason |
|---|---|---|---|---|---|---|---|
| Attitudes | 12 | 12 | 0.906 | 0.906 | Excellent reliability | None | All items retained |
| Beliefs | 8 | 6 | 0.786 | 0.897 | Good reliability | B5, B6 | Improved internal consistency and conceptual refinement of therapeutic and clinical integration beliefs |
| Domain | Initial items | Final items | KR-20 coefficient (Initial) | KR-20 coefficient (Final) | Interpretation | Removed Items | Reason |
| Knowledge | 18 | 16 | 0.708 | 0.734 | Acceptable reliability | K12 and K17 | Improved internal consistency |
References
- Hameed, M.; Prasad, S.; Jain, E.; Dogrul, B.N.; Al-Oleima, A.; Pokhrel, B.; et al. Medical cannabis for chronic nonmalignant pain management. Curr. Pain Headache Rep. 2023, 27(4), 57–63. [Google Scholar] [CrossRef] [PubMed]
- Legare, C.A.; Raup-Konsavage, W.M.; Vrana, K.E. Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacol. 2022, 107(3–4), 131–49. [Google Scholar] [CrossRef] [PubMed]
- Singh, K.; Bhushan, B.; Chanchal, D.K.; Sharma, S.K.; Rani, K.; Yadav, M.K.; et al. Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review. Behav. Neurol. 2023, 2023, 8825358. [Google Scholar] [CrossRef] [PubMed]
- Abrams, D.I. The therapeutic effects of cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine report. Eur. J. Intern Med. 2018, 49, 7–11. [Google Scholar] [CrossRef] [PubMed]
- Hong, G.; Sideris, A.; Waldman, S.; Stauffer, J.; Wu, C.L. Legal and regulatory aspects of medical cannabis in the United States. Anesth. Analg. 2024, 138(1), 31–41. [Google Scholar] [CrossRef] [PubMed]
- Shim, M.; Nguyen, H.; Grootendorst, P. Lessons from 20 years of medical cannabis use in Canada. PLoS ONE 2023, 18(3), e0271079. [Google Scholar] [CrossRef] [PubMed]
- Assanangkornchai, S.; Thaikla, K.; Talek, M.; Saingam, D. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey. PeerJ. 2022, 10, e12809. [Google Scholar] [CrossRef] [PubMed]
- Szafarski, M.; McGoldrick, P.; Currens, L.; Blodgett, D.; Land, H.; Szafarski, J.P.; Segal, E. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists. Epilepsy Behav. EB 2020, 109, 107102. [Google Scholar] [CrossRef]
- Ziemianski, D.; Capler, R.; Tekanoff, R.; Lacasse, A.; Luconi, F.; Ware, M.A. Cannabis in medicine: a national educational needs assessment among Canadian physicians. BMC Med. Educ. 2015, 15, 52. [Google Scholar] [CrossRef] [PubMed]
- Zolotov, Y.; Cohen, O.G.; Findley, P.A.; Reznik, A.; Isralowitz, R.; Willard, S. Attitudes and knowledge about medical cannabis among Israeli and American nursing students. Nurse Educ. Today 2021, 99, 104789. [Google Scholar] [CrossRef] [PubMed]
- Sokratous, S.; Mpouzika, M.D.; Kaikoushi, K.; Hatzimilidonis, L.; Koutroubas, V.S.; Karanikola, M.N. Medical cannabis attitudes, beliefs and knowledge among Greek-Cypriot University nursing students. Complement Ther. Med. 2021, 58, 102707. [Google Scholar] [CrossRef] [PubMed]
- Khamenka, N.; Pikirenia, U. Knowledge, attitudes and beliefs about medical cannabis among the medical students of the Belarus State Medical University. Complement Ther. Med. 2021, 57, 102670. [Google Scholar] [CrossRef] [PubMed]
- Balneaves, L.G.; Watling, C.Z.; Strus, J.A.; Boscow, M.; Davis, L.; Graveline, K.; et al. Baccalaureate nursing students’ knowledge, attitudes, educational needs, and use of medical and non-medical cannabis at five institutions in Manitoba, Canada: a cross-sectional analysis. Nurse Educ. Today 2023, 130 105955. [Google Scholar] [CrossRef] [PubMed]
- Government of Vietnam. The Government; Hanoi Decree No. 105/2021/ND-CP: Detailing and guiding the implementation of a number of articles of the Law on Drug Prevention and Control [Internet]. , 4 Dec 2021. Available online: https://english.luatvietnam.vn/decree-no-105-2021-nd-cp-of-the-government-detailing-and-guiding-the-implementation-of-a-number-of-articles-of-the-law-on-dru-213690-doc1.html (accessed on 1 Apr 2025).
- Sokratous, S.; Kaikoush, K.; Mpouzika, M.D.; Alexandrou, G.; Karanikola, N.M. Attitudes, beliefs and knowledge about medical cannabis among nurses and midwives in Cyprus: a cross-sectional descriptive correlational study. BMC Nurs. 2022, 21(1), 120. [Google Scholar] [CrossRef] [PubMed]
- Balneaves, L.G.; Alraja, A.; Ziemianski, D.; McCuaig, F.; Ware, M. A national needs assessment of Canadian nurse practitioners regarding cannabis for therapeutic purposes. Cannabis Cannabinoid Res. 2018, 3(1), 66–73. [Google Scholar] [CrossRef]
- Pereira, L.; Núñez-Iglesias, M.J.; Domínguez-Martís, E.M.; López-Ares, D.; González-Peteiro, M.; Novío, S. Nursing students’ knowledge and attitudes regarding medical marijuana: a descriptive cross-sectional study. Int. J. Env. Res. Public Heal. 2020, 17(7), 2492. [Google Scholar] [CrossRef] [PubMed]
- Felnhofer, A.; Kothgassner, O.D.; Stoll, A.; Klier, C. Knowledge about and attitudes towards medical cannabis among Austrian university students. Complement Ther. Med. 2021, 58, 102700. [Google Scholar] [CrossRef] [PubMed]
- Yusoff, M.S. ABC of content validation and content validity index calculation. Educ. Med. J. 2019, 11, 4954. [Google Scholar] [CrossRef]
- Zamanzadeh, V.; Ghahramanian, A.; Rassouli, M.; Abbaszadeh, A.; Alavi-Majd, H.; Nikanfar, A.R. Design and implementation content validity study: development of an instrument for measuring patient-centered communication. J. Caring Sci. 2015, 4, 165–78. [Google Scholar] [CrossRef] [PubMed]
- George, D.; Mallery, P. IBM SPSS statistics 29 step by step: A simple guide and reference. routledge 2024. [Google Scholar]
- Vujcic, I.; Pavlovic, A.; Dubljanin, E.; Maksimovic, J.; Sipetic-Grujicic, S. Attitudes toward medical cannabis legalization among Serbian medical students. Subst. Use Misuse. 2017, 52(9), 1229–35. [Google Scholar] [CrossRef]
- Jacobs, R.J.; Kane, M.N.; Caballero, J. Predictors of medical students’ perceptions about medical cannabis. Cureus 2022, 14(4). [Google Scholar] [CrossRef] [PubMed]
| Variables | Values | |
|---|---|---|
| Social-demographic characteristics Age |
Median [Range] or n (%) 20 [18,19,20,21,22,23,24,25] |
|
Gender
|
322 (76.3) 100 (23.7) |
|
Academic year
|
120 (28.4) 114 (27.0) 110 (26.1) 78 (18.5) |
|
Religion
|
120 (28.4) 302 (71.6) |
|
| Knowledge regarding MC | Mean ± SD (Maximum score) | % of Maximum score |
| Total knowledge score | 8.34 ± 2.83 (16) | 52.1% |
|
1.84 ± 1.01 (3) 3.21 ± 1.38 (6) 1.77 ± 1.0 (4) 2.21 ± 0.97 (3) |
61.3% 53.5% 44.3% 73.7% |
| Attitude towards MC | Mean ± SD (Maximum score) | % of Maximum score |
Total attitude score
|
44.11 ± 6.55 (60) 15.50 ± 2.54 (20) 6.86 ± 1.33 (10) 6.79 ± 1.40 (10) 7.65 ± 1.45 (10) 7.33 ± 1.40 (10) |
73.5% 77.5% 68.6% 67.9% 76.5% 73.3% |
| Beliefs regarding MC | Mean ± SD (Maximum score) | % of Maximum score |
Total beliefs score
|
20.44 ± 3.71 (30) 13.69 ± 2.50 (20) 6.74 ± 1.39 (10) |
68.1% 68.5% 67.4% |
| Intentions to support legalization of MC | n (%) | |
|
47 (11.1) 237 (56.2) 138 (32.7) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).